CTRI/2020/04/024924尚未招募不适用
Discriminant Validity of Upper Extremity Movement Capacity in Individuals with and without Stroke
BeAble Health Pvt Ltd1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2020年1月5日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Total distance covered by the upper extremity in centimeters
研究概览
简要总结
This is an observational, single center study testing discriminant validity of upper extremity movement capacity by comparing the movement capacity between individuals with and without stroke that will be conducted at Kasturba Hospital, Manipal, India. The primary outcome measure is the total distance covered by the upper extremity in centimeters. The secondary outcome measures are the total duration of movement in seconds, the speed of movement in centimetres per second, the movement pattern and the accuracy of the movement i.e. the number of targets reached.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 69.00 Year(s)(—)
- 性别
- All
入选标准
- •First unilateral stroke with hemiparesis/hemiplegia Brunnstrom Motor Recovery stage ≥ 2 Medically stable patients Patients with functional vision Patients who can understand simple instructions and follow commands Patients who can sit independently with or without support.
排除标准
- •Perceptual dysfunction Aphasia Recent musculoskeletal injuries of the upper extremity Shoulder subluxation Shoulder pain Complex Regional Pain Syndrome.
结局指标
主要结局
Total distance covered by the upper extremity in centimeters
时间窗: One time point
次要结局
- 1.Total duration of movement in seconds(2.Speed of movement (cm/s))
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Improving Hepatocellular Carcinoma ScreeningMagnetic Resonance ImagingScreeningContrast-enhanced USHepatocellular CarcinomaNCT05828446Naik Vietti Violi330
Unknown
不适用
OPS™ With Direct Anterior Approach (DAA)Primary Total Hip ArthroplastyNCT04319952Corin100
已完成
2 期
Botulinum Toxin A to Treat Arm TremorEssential Tremor of the Upper LimbsNCT02207946Merz Pharmaceuticals GmbH30
撤回
不适用
Clinical Investigation to Determine the Accuracy and Benefit of Cardioskin™ in Patients With Known Atrial FibrillationAtrial FibrillationNCT03964025Institut de Recherches Internationales Servier
尚未招募
2 期
Fluzopari Combined With Apatinib for the Neoadjuvant Treatment of Unresectable Ovarian CancerOvarian CancerNCT05597527Fujian Cancer Hospital35
